Southern Star Research Logo

U.S. Roadshow: Accelerate Your Biotech’s Clinical Development in Australia

June 2025
Salt Lake City, Boston & BIO International Convention

Southern Star Research is heading to the U.S. this June! Join our Director of Business Development, Dan Evans, as he meets with early-stage biotech companies and investors across Salt Lake City and Boston, wrapping up at the BIO International Convention 2025.

This exclusive roadshow is your opportunity to discover how Australia’s clinical trial landscape offers a uniquely stable, cost-effective, and accelerated pathway to early-phase clinical development.

U.S. Roadshow Dates

  • Salt Lake City, UT: June 2 – 6
  • Boston, MA: June 9 – 13
  • BIO International Convention (Boston): June 16 – 20

Why Meet with Southern Star Research:

  • Learn how Australian clinical trials can rapidly accelerate your clinical timeline.
  • Connect directly with Southern Star Research’s for personalised strategy sessions.
  • Explore cost-saving opportunities and regulatory efficiencies.

Why Leading Biotechs Choose Australia for Early-Phase Trials

In today’s uncertain global landscape, biotech leaders are seeking predictability, security, and speed—Australia offers all three.

  • Australia consistently ranks among the most politically stable countries globally, with a transparent regulatory environment that supports innovation and minimizes delays.
  • With high-quality infrastructure and internationally accredited research institutions, Australia is recognized as a trusted destination for early-phase trials.
  • Access a fast-track approval system that doesn’t compromise on ethics or quality—no IND required to start clinical trials.
  • Take advantage of the 43.5% R&D Tax Incentive, creating substantial cost savings for offshore companies.

Book a One-on-One with our Southern Star Research expert

This is your chance to explore how Southern Star Research can help accelerate your clinical development plans while ensuring the security and quality your trial needs.

Whether you’re exploring your first-in-human trial or expanding your global footprint, Australia offers an unmatched clinical trial advantage—and Southern Star Research is your trusted CRO partner on the ground.

Book a Meeting with Dan Evans by submitting the form.

Schedule a meeting

U.S. Roadshow GF

"*" indicates required fields

Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.

The Australian Advantage

Cost

Eligible organisations receive a 43.5% cash rebate on trial costs with the Australian Research & Development tax incentive.

Speed

Get you trial up and running in 8 weeks with streamlined ethics approvals and no need for an Investigational New Drug application.

Quality

World-class healthcare facilities and renowned experts ensure your data is accepted by international regulatory bodies like the FDA and EMA.

Come and meet us

Our team will be available throughout this event to discuss how we can support your research initiatives. Whether you’re looking to start a new project, save an existing one or simply explore new partnership opportunities, we’re here to help.

Daniel Evans

Director, Business Development

  • Located in Sydney, Australia
  • 10+ years of experience in biotech consulting and CRO industry
  • Strong expertise in global business development for biotech and pharma
  • Deep understanding of biotech needs and challenges
  • Extensive experience in partnering with global biotech to deliver fast, cost-effective, high-quality clinical trial.
Head Office:

L1, 1 Merriwa Street,

Gordon, NSW, 2072 Australia

Connect with us

Sign up to our newsletter

Keep up to date with the latest news, updates and promotions

Copyright 2025 Southern Star Research Pty Ltd

Privacy Policy Legal Notice
icon of a head

Specialist experience

Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study  clinical trial is handled with scientific precision, care, and foresight.

Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.

We recognize that each study is unique and different and there are nuances that need to be resolved proactively.

Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.